Evidence map›Paper›PMID 31392370›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Al

Karolien Goffin

Open access · bronzeAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Head to head comparison of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Pathological validation ofScientific reports · 2025
    Article
  4. Review
  5. Superior lesion detection withQuantitative imaging in medicine and surgery · 2025
    Article
  6. Observational
  7. Role ofFrontiers in medicine · 2025
    Article
  8. Frontiers in endocrinology · 2024
    Review
  9. Article
  10. Biodistribution ofMolecular imaging and biology · 2021
    Article
  11. Review
  12. [Cancers · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Karolien GoffinNuclear Medicine, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium. Karolien.goffin@uzleuven.be.ORCID 0000-0002-7453-0229
Universitair Ziekenhuis Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

OctreotideReceptors, SomatostatinFluorine RadioisotopesHeterocyclic Compounds, 1-Ring1,4,7-triazacyclononane-N,N',N''-triacetic acidFluorine RadioisotopesHeterocyclic Compounds, 1-RingOctreotideReceptors, Somatostatin

Identifiers

PMID31392370
OpenAlexW2965699550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.